Prevention & lipidsCohort study

Urine cadmium and the risk of cardiovascular morbidity and mortality: results from the Chang Gung Research Database

Eur J Prev CardiolPublished

  • Retrospective cohort study

Authors' conclusion

Cd exposure was associated with an increased risk of cardiovascular morbidity and mortality in this representative Asian population.

Study context

Population
Adults from Taiwan with urine cadmium assessments in the Chang Gung Research Database
Participants
10,713 adults
Exposure
Highest vs lowest urine cadmium quartile
Outcome
MACCE:
  • AMI
  • Coronary intervention
  • Ischaemic stroke
  • CV mortality

Main finding

MACCE

Hazard ratio

1.88

95% CI 1.20–2.95

Q4 vs Q1
HR 1.88 (95% CI 1.20–2.95)

As reported in the abstract

Observational data: associations, not effects.

Secondary outcomes

OutcomeHR (95% CI)
Ischaemic stroke · fully adjusted Cox model2.22 (1.07–4.61)
CV mortality · fully adjusted Cox model2.56 (1.17–5.60)
All-cause mortality · fully adjusted Cox model1.67 (1.22–2.29)

Major adverse coronary events (MACE) (acute myocardial infarction (AMI) and coronary intervention)

No significant association observed for MACE
1.62 (HR 1.62; 95% CI 0.75-3.50)

Dose-response (restricted cubic spline)

Positive, non-linear relationship between continuous urine cadmium (U-Cd) and outcomes; approximately linear up to U-Cd around 1.3 μg/g creatinine, then plateau

Major adverse cardiac and cerebrovascular events (MACCE) by subgroup

Association between U-Cd and MACCE consistent across all analysed subgroups, including never-smokers, ever-smokers and both sexes

Original publication

Urine cadmium and the risk of cardiovascular morbidity and mortality: results from the Chang Gung Research Database. Eur J Prev Cardiol. Published 12 July 2025. doi:10.1093/eurjpc/zwaf413

Summarised from the published abstract; every number is checked against it